Literature DB >> 11192465

Recovery from severe arsenic-induced peripheral neuropathy with 2,3-dimercapto-1-propanesulphonic acid.

P M Wax1, C A Thornton.   

Abstract

CASE REPORT: A 33-year-old female with a 1.5-year history of multisystem illness was diagnosed with arsenic poisoning. Twenty-four-hour urine arsenic was 1030 microg/dL (normal 0-99) and root hair arsenic was 130 microg/g (normal 0-3). Despite treatment with succimer meso-2,3-dimercaptosuccinic acid, her neuropathy progressed to ventilator dependence and quadriplegia. Subsequent intravenous treatment with 2,3-dimercapto-1-propanesulfonic acid sodium salt was associated with arsenic diuresis, marked neuropathic improvement, and extubation. At 1-year follow-up, neuropathy was limited to mild distal lower extremity weakness and sensory loss. The use of 2,3-dimercapto-1-propanesulphonic acid in the treatment of severe arsenic neuropathy was associated with increased urinary elimination of arsenic and dramatic clinical recovery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11192465     DOI: 10.1081/clt-100102391

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  4 in total

1.  Acute peripheral polyneuropathy with multiorgan failure: a diagnostic dilemma.

Authors:  Kosar Hussain; Jawed Abubaker; Javeed Ahmad Dar; Raees Ahmed
Journal:  BMJ Case Rep       Date:  2014-06-04

2.  Plasma and urine dimercaptopropanesulfonate concentrations after dermal application of transdermal DMPS (TD-DMPS).

Authors:  Jennifer P Cohen; Anne-Michelle Ruha; Steven C Curry; Kallol Biswas; Benjamin Westenberger; Wei Ye; Kathleen L Caldwell; Frank Lovecchio; Keith Burkhart; Nasr Samia
Journal:  J Med Toxicol       Date:  2013-03

Review 3.  Arsenic Toxicity: Molecular Targets and Therapeutic Agents.

Authors:  Valeria M Nurchi; Aleksandra Buha Djordjevic; Guido Crisponi; Jan Alexander; Geir Bjørklund; Jan Aaseth
Journal:  Biomolecules       Date:  2020-02-04

4.  Treatment of lead and arsenic poisoning in anuric patients - a case report and narrative review of the literature.

Authors:  Chun-Yuan Hsiao; Chip Gresham; Mark R Marshall
Journal:  BMC Nephrol       Date:  2019-10-17       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.